Growth hor­mone from No­vo Nordisk is in short­age over man­u­fac­tur­ing de­lays

No­vo Nordisk’s growth hor­mone Norditropin is in short­age be­cause of man­u­fac­tur­ing de­lays, ac­cord­ing to an FDA site that tracks drug short­ages as well as the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.